Steven Z. Pavletic, M.D., M.S


Dr Pavletic received his M.D. from the University of Zagreb School of Medicine in Croatia in 1979. In 1992, he completed a clinical fellowship in bone marrow transplantation at the Fred Hutchinson Cancer Research Center and University of Washington Medical School in Seattle, WA. In 1995, he completed his internal medicine residency at the University of Nebraska Medical Center (UNMC) in Omaha, NE, and completed his hematology and oncology fellowship in June 1997.

Academic Interests: 

• Graft Versus Host Disease 

Professional highlights: 

  • From 1999 until 2002 he was the Director of the Allogeneic Stem Cell Transplantation program at the University of Nebraska.
  • Currently, he is the Head of the Graft-versus-host disease (GVHD) and Autoimmunity Unit and Senior Clinician at the Experimental Transplantation and Immunology Branch of the National Cancer Institute's (NCI) Center for Cancer Research at the U.S. National Institutes of Health (NIH).
  • He is presently also an Adjunct Professor of Medicine and Oncology at Lombardi Cancer Center, Georgetown University, Washington, D.C.
  •  President of Hrvatska ura (HURA), a Washington, D.C.-based initiative established in 2010 with the goal of building cultural, economic and scientific ties between the United States and Croatia by working with the Croatian American community.
  • Vice president of the Association of Croatian American Professionals and is president of its Medicine and Health Sciences Section.


  • In October 2006 Pavletic received the National Cancer Institute (NCI) Director's Individual Merit Award for his achievements in developing national and international consensus guidelines for clinical trials in chronic GVHD, which enabled research to be conducted on one of the most serious late effect cancer treatment complications in already cured patients.
  • Pavletic was recognized in May 2007 by the Croatian Society of Oncology for his efforts at initiating an NIH-European-Croatian expert consortium with the goal of developing strategies for the national cancer control program in Croatia.This cooperation paved the way towards the signing of an agreement in 2010 between the United States and Croatia to foster educational cooperation and training in clinical oncology.
  • In 2013 the Zagreb chronic GVHD team was awarded an international peer-reviewed grant through the Unity Through Knowledge Fund (UKF).


  • Pavletic has published more than 200 articles in peer-reviewed journals. 
  • He is the chief editor of the first textbook on GVHD entitled “Chronic Graft Versus Host Disease: Interdisciplinary Management”, published in 2009. 
  • Six articles on a 2005 international consensus project for clinical trials in chronic GVHD were referenced more than 1600 times in peer-reviewedliterature